Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Total revenue	$ 148	$ 66
Operating expenses:
Research and development	10,397	6,615
General and administrative	7,168	8,344
Total operating expenses	17,565	14,958
Loss from operations	(17,417)	(14,892)
Other income (expense), net	5,723	1,536
Loss before provision for income taxes	(11,694)	(13,356)
Provision for income taxes	0	0
Net loss	$ (11,694)	$ (13,356)
Net loss per share, basic (in dollars per share)	$ (0.17)	$ (0.19)
Net loss per share, diluted (in dollars per share)	$ (0.17)	$ (0.19)
Weighted-average common shares outstanding, basic (in shares)	70,716,929	70,490,704
Weighted-average common shares outstanding, diluted (in shares)	70,716,929	70,490,704